What is the share price of Alembic Ltd (ALEMBICLTD) today?
The share price of ALEMBICLTD as on 1st July 2025 is ₹123.03. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Alembic Ltd (ALEMBICLTD) share?
The past returns of Alembic Ltd (ALEMBICLTD) share are- Past 1 week: 8.35%
- Past 1 month: 10.20%
- Past 3 months: 23.29%
- Past 6 months: -7.13%
- Past 1 year: 8.06%
- Past 3 years: 96.53%
- Past 5 years: 55.54%
What are the peers or stocks similar to Alembic Ltd (ALEMBICLTD)?
The peers or stocks similar to Alembic Ltd (ALEMBICLTD) include:What is the dividend yield % of Alembic Ltd (ALEMBICLTD) share?
The current dividend yield of Alembic Ltd (ALEMBICLTD) is 1.95.What is the market cap of Alembic Ltd (ALEMBICLTD) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alembic Ltd (ALEMBICLTD) is ₹3159.19 Cr as of 1st July 2025.What is the 52 week high and low of Alembic Ltd (ALEMBICLTD) share?
The 52-week high of Alembic Ltd (ALEMBICLTD) is ₹169 and the 52-week low is ₹85.46.What is the PE and PB ratio of Alembic Ltd (ALEMBICLTD) stock?
The P/E (price-to-earnings) ratio of Alembic Ltd (ALEMBICLTD) is 10.17. The P/B (price-to-book) ratio is 1.45.Which sector does Alembic Ltd (ALEMBICLTD) belong to?
Alembic Ltd (ALEMBICLTD) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Alembic Ltd (ALEMBICLTD) shares?
You can directly buy Alembic Ltd (ALEMBICLTD) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Alembic Ltd
ALEMBICLTD Share Price
ALEMBICLTD Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ALEMBICLTD Performance & Key Metrics
ALEMBICLTD Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
10.17 | 1.45 | 1.95% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.48 | 6.57 | 0.80% |
ALEMBICLTD Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
ALEMBICLTD Company Profile
Alembic Limited is engaged in the business of pharmaceuticals, real estate and power assets. The Company's segments include API and Real Estate.
ALEMBICLTD Forecast
ALEMBICLTD Forecasts
ALEMBICLTD
ALEMBICLTD
Income
Balance Sheet
Cash Flow
ALEMBICLTD Income Statement
ALEMBICLTD Income Statement
Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 178.13 | 162.32 | 153.26 | 167.33 | 83.79 | 167.40 | 191.50 | 212.26 | 296.78 | 296.77 | ||||||||||
Raw Materials | 50.97 | 39.86 | 45.21 | 24.59 | 11.77 | 8.53 | 6.92 | 8.62 | 128.18 | 128.17 | ||||||||||
Power & Fuel Cost | 5.46 | 1.11 | 2.34 | 0.91 | 0.42 | 0.15 | 2.02 | 1.18 | ||||||||||||
Employee Cost | 28.64 | 19.64 | 20.52 | 20.79 | 22.60 | 21.47 | 24.04 | 23.03 | ||||||||||||
Selling & Administrative Expenses | 7.38 | 7.13 | 7.26 | 9.17 | 7.56 | 9.82 | 10.81 | 14.04 | ||||||||||||
Operating & Other expenses | 53.80 | 46.45 | 30.41 | 15.19 | 20.10 | 24.33 | 53.73 | 53.76 | ||||||||||||
EBITDA | 31.88 | 48.13 | 47.52 | 96.68 | 21.34 | 103.10 | 93.98 | 111.63 | 168.60 | 168.60 | ||||||||||
Depreciation/Amortization | 5.09 | 3.78 | 2.63 | 3.23 | 3.94 | 4.86 | 6.72 | 7.84 | 10.63 | 10.62 | ||||||||||
PBIT | 26.79 | 44.35 | 44.89 | 93.45 | 17.40 | 98.24 | 87.26 | 103.79 | 157.97 | 157.98 | ||||||||||
Interest & Other Items | 0.16 | 0.17 | 0.22 | 0.29 | 0.36 | 0.39 | 0.47 | 1.11 | 2.47 | 2.47 | ||||||||||
PBT | 26.63 | 44.18 | 44.67 | 93.16 | 17.04 | 97.85 | 86.79 | 102.68 | 155.50 | 155.51 | ||||||||||
Taxes & Other Items | -118.75 | -118.81 | -168.43 | -235.95 | -325.80 | -124.20 | -103.85 | -165.93 | -155.18 | -155.17 | ||||||||||
Net Income | 145.38 | 162.99 | 213.10 | 329.11 | 342.84 | 222.05 | 190.64 | 268.61 | 310.68 | 310.68 | ||||||||||
EPS | 4.43 | 4.97 | 6.62 | 11.50 | 13.35 | 8.65 | 7.42 | 10.46 | 12.10 | 12.10 | ||||||||||
DPS | 0.16 | 0.16 | 0.16 | 0.60 | 0.20 | 1.80 | 2.20 | 2.40 | 2.40 | 2.40 | ||||||||||
Payout ratio | 0.04 | 0.03 | 0.02 | 0.05 | 0.01 | 0.21 | 0.30 | 0.23 | 0.20 | 0.20 |
ALEMBICLTD Company Updates
ALEMBICLTD Stock Peers
ALEMBICLTD Past Performance & Peer Comparison
ALEMBICLTD Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Alembic Ltd | 10.17 | 1.45 | 1.95% |
Sun Pharmaceutical Industries Ltd | 36.60 | 5.96 | 0.96% |
Cipla Ltd | 23.22 | 3.91 | 1.06% |
Torrent Pharmaceuticals Ltd | 60.51 | 16.87 | 0.94% |
ALEMBICLTD Stock Price Comparison
Compare ALEMBICLTD with any stock or ETFALEMBICLTD Holdings
ALEMBICLTD Shareholdings
ALEMBICLTD Promoter Holdings Trend
ALEMBICLTD Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
ALEMBICLTD Institutional Holdings Trend
ALEMBICLTD Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
ALEMBICLTD Shareholding Pattern
ALEMBICLTD Shareholding Pattern
ALEMBICLTD Shareholding History
ALEMBICLTD Shareholding History
smallcases containing ALEMBICLTD stock
smallcases containing ALEMBICLTD stock
Looks like this stock is not in any smallcase yet.
ALEMBICLTD Events
ALEMBICLTD Events
ALEMBICLTD Dividend Trend
ALEMBICLTD has increased or maintained dividend levels over the last 5 years
Current dividend yield is 1.95%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.51 every year
Dividends
Corp. Actions
Announcements
Legal Orders
ALEMBICLTD Dividend Trend
ALEMBICLTD has increased or maintained dividend levels over the last 5 years
Current dividend yield is 1.95%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.51 every year
ALEMBICLTD Upcoming Dividends
ALEMBICLTD Upcoming Dividends
No upcoming dividends are available
ALEMBICLTD Past Dividends
ALEMBICLTD Past Dividends
Cash Dividend
Ex DateEx DateAug 5, 2024
Dividend/Share
₹2.40
Ex DateEx Date
Aug 5, 2024
Cash Dividend
Ex DateEx DateAug 3, 2023
Dividend/Share
₹2.20
Ex DateEx Date
Aug 3, 2023
Cash Dividend
Ex DateEx DateSep 12, 2022
Dividend/Share
₹1.80
Ex DateEx Date
Sep 12, 2022
Cash Dividend
Ex DateEx DateJul 29, 2021
Dividend/Share
₹0.20
Ex DateEx Date
Jul 29, 2021
Cash Dividend
Ex DateEx DateJul 29, 2020
Dividend/Share
₹0.60
Ex DateEx Date
Jul 29, 2020
ALEMBICLTD Stock News & Opinions
ALEMBICLTD Stock News & Opinions
Alembic announced that the Board of Directors of the Company at its meeting held on 13 May 2025, inter alia, have recommended the final dividend of Rs 2.4 per equity Share (i.e. 120%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of Alembic declined 5.13% to Rs 68.45 crore in the quarter ended March 2025 as against Rs 72.15 crore during the previous quarter ended March 2024. Sales rose 22.90% to Rs 60.27 crore in the quarter ended March 2025 as against Rs 49.04 crore during the previous quarter ended March 2024. For the full year,net profit rose 15.66% to Rs 310.68 crore in the year ended March 2025 as against Rs 268.62 crore during the previous year ended March 2024. Sales rose 40.89% to Rs 221.89 crore in the year ended March 2025 as against Rs 157.49 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales60.2749.04 23 221.89157.49 41 OPM %45.3549.25 -42.2336.11 - PBDT29.6725.71 15 166.13110.53 50 PBT26.9224.23 11 155.50102.69 51 NP68.4572.15 -5 310.68268.62 16 Powered by Capital Market - Live
Alembic will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
Profit before tax (PBT) was at Rs 27.39 crore in Q3 FY25, up 151.75% as against Rs 10.88 crore reported in the same period a year ago. Total expense jumped 13.79% year on year to Rs 34.90 crore during the quarter. Employee benefit expense stood at Rs 6.56 crore (up 17.56% YoY), while cost of materials consumed was at Rs 1.81 crore (up 14.56% YoY) during the period under review. The company's revenue from the active pharmaceutical ingredients business was at Rs 6.25 crore (down 3.55% YoY), while the real estate business came in at Rs 51.67 crore (up 57.29% YoY) during the period under review. On a 9-month basis, the net profit surged 68.8% to Rs 120.83 crore on a 49.04% rise in revenue from operations to Rs 161.62 crore in 9M FY25 over 9M FY24. Alembic is dealing in the Active Pharmaceutical Ingredient (API) Business and Real Estate Business. Shares of Alembic fell 1.69% to Rs 110.85 on the BSE.Powered by Capital Market - Live
Net profit of Alembic rose 6.50% to Rs 65.39 crore in the quarter ended December 2024 as against Rs 61.40 crore during the previous quarter ended December 2023. Sales rose 47.30% to Rs 57.92 crore in the quarter ended December 2024 as against Rs 39.32 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales57.9239.32 47 OPM %45.5829.68 - PBDT30.0813.53 122 PBT27.3910.87 152 NP65.3961.40 6 Powered by Capital Market - Live
Alembic will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live
Net profit of Alembic rose 33.46% to Rs 121.02 crore in the quarter ended September 2024 as against Rs 90.68 crore during the previous quarter ended September 2023. Sales rose 63.91% to Rs 52.91 crore in the quarter ended September 2024 as against Rs 32.28 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales52.9132.28 64 OPM %37.0131.44 - PBDT84.5157.89 46 PBT81.8356.03 46 NP121.0290.68 33 Powered by Capital Market - Live
Alembic will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Net profit of Alembic rose 25.78% to Rs 55.82 crore in the quarter ended June 2024 as against Rs 44.38 crore during the previous quarter ended June 2023. Sales rose 37.84% to Rs 50.78 crore in the quarter ended June 2024 as against Rs 36.84 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales50.7836.84 38 OPM %40.1729.53 - PBDT21.8713.38 63 PBT19.3711.55 68 NP55.8244.38 26 Powered by Capital Market - Live
Alembic’s shares dip amidst US market product recall

Over the last 5 years, revenue has grown at a yearly rate of 12.14%, vs industry avg of 10.2%
Over the last 5 years, market share stayed at 0.07%
Over the last 5 years, net income has grown at a yearly rate of -1.15%, vs industry avg of 20.11%